Orthopaedics · Joint replacement

Knee osteoarthritis treatment in China

Full-spectrum knee OA care at Class A orthopaedic and sports medicine centres — conservative management, BMAC and PRP, and total knee replacement with international-brand implants.

← All conditions

Overview

Knee osteoarthritis is the most common joint disease globally and a leading cause of disability. Class A orthopaedic centres in China cover the full spectrum: structured physiotherapy, intra-articular injections (HA, PRP, BMAC), and total knee arthroplasty with international-brand implants. The cost differential vs US private pay is substantial across all stages.

Common symptoms

  • Knee pain with weight-bearing, climbing stairs, or after extended activity
  • Morning stiffness <30 minutes
  • Reduced range of motion
  • Crepitus (grinding) with movement
  • Joint effusion in advanced disease

Risk factors

  • Age (most common over 50)
  • Female sex
  • Higher BMI (each 1 kg = ~4 kg peak knee load)
  • Prior meniscus or ACL injury
  • Occupational repetitive loading
  • Family history

Standard diagnostic workup

Cost band at Class A international department: USD 90180 all-in.

  • Standing AP + lateral knee X-rays
  • MRI if soft-tissue / meniscus pathology suspected
  • Functional assessment (KOOS-PS or WOMAC)
  • BMI assessment, lower-extremity alignment evaluation

Treatment options

First-line

Quad-strengthening physiotherapy

Foundational — strong evidence for slowing OA progression.

First-line

Weight management

Each 1 kg lost reduces peak knee load by ~4 kg. GLP-1 medication is increasingly part of the conservative strategy.

Details →

First-line

NSAIDs / topical analgesics

First-line pharmacotherapy. Topical when systemic risks are concerning.

Second-line

Intra-articular hyaluronic acid

Modest evidence for symptomatic relief in early-to-moderate OA.

Second-line

PRP injection

Growing evidence for early-to-moderate OA. China price USD 200–500 per session vs USD 700–2,000 US.

Selected cases

Bone marrow aspirate concentrate (BMAC)

Class A sports medicine programmes (Shanghai Ninth, PKU Third). Evidence for early-to-moderate OA. USD 1,400–2,800 per knee.

Advanced disease

Total knee arthroplasty (TKA)

Indicated for advanced OA with persistent pain and functional limitation despite conservative care. International-brand implants. USD 9,500–14,000 all-in.

Details →

Frequently asked

How disabled am I — is surgery indicated?
Take our KOOS-PS knee function self-test for a structured 0–100 score that orthopaedic surgeons use directly.
Should I try BMAC or stem cell before surgery?
For early-to-moderate OA (KL grade 2–3) with adequate functional capacity, BMAC and PRP have meaningful evidence. For advanced bone-on-bone OA, BMAC rarely changes the eventual need for arthroplasty. See our evidence reality check.
Are international-brand implants used?
Yes — Zimmer, Stryker, DePuy, Smith & Nephew are routinely used at Class A international departments. Domestic-brand implants are also approved if cost-prioritised.

Talk to a senior physician

Free 30-minute video consult to review your case. We'll quote a workup and treatment plan at a Class A partner hospital — no commitment.

Book free consult